No More Vaccines? Research Funding? Paul Hastings, CEO, Nkarta and former Chair, BIO
This week on Biotech Nation, Paul Hastings, CEO of Nkarta and former chair of BIO—the Biotechnology Innovation Organization—discusses the impact of cuts to research funding and stepping away from recommending vaccines—what this means for you and the biotech industry.
